(Q48377344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

0 references

1 reference

Acute decompensated heart failure

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ana Azevedo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Paulo Bettencourt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Fernando Friões

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Patrícia Lourenço

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Olga Laszczyńska

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Pedro-Bernardo Almeida

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

James L Januzzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

14 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

Clinical Research in Cardiology

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

491-499

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00392-015-0811-x

27 February 2020

exact match

0 references

cites work

Biomarkers in heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

State of the art: using natriuretic peptide levels in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Novel markers for heart failure diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Biomarkers and diagnostics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Heart failure with preserved ejection fraction: an ongoing enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-015-0811-X

Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure

21 January 2018

1 reference

12 December 2020

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

1 reference

12 December 2020

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

12 December 2020

Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure

1 reference

12 December 2020

Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling

1 reference

12 December 2020

10.1007/S00392-015-0811-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25586507%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference